As of 22 Sept 2026, Dr Lal Pathlabs Ltd share price is ₹1,916.30. The stock opened at ₹1,916.30 and had closed at ₹1,895.85 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹1,272.00 and a high of ₹2,035.00. In terms of performance, Dr Lal Pathlabs Ltd share price has increased by 46.67% over the past six months and has increased by 15.11% over the last year.
LALPATHLAB Stock Price Chart
Dr Lal Pathlabs Ltd Overview
About LALPATHLAB
Dr. Lal PathLabs engaged in the business of running laboratories for carrying out pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology,
Dr Lal Pathlabs Ltd Historical Performance
Dr Lal Pathlabs Ltd Fundamentals
Dr Lal Pathlabs Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 2,760.30 | 2,463.10 | 2,191.40 | 1,815.60 | 1,931.90 |
| EBITDA | 836.30 | 777.00 | 646.90 | 507.30 | 565.50 |
| Net Profit | 508.20 | 497.30 | 346.70 | 292.40 | 345.30 |
| EPS | 30.45 | 59.70 | 41.72 | 35.28 | 41.61 |
Dr Lal Pathlabs Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 1,866.95 |
| Resistance 1 (R1) | 1,942.00 |
| Pivot Point | 1,913.10 |
Dr Lal Pathlabs Ltd Dividend History
| Ex Date | Dividends Date | Record Date | Dividend Type | Dividend Details |
|---|---|---|---|---|
| 30-Jul-2026 | 24-Jul-2026 | 30-Jul-2026 | Interim | ₹5.00 |
| 25-Jun-2026 | 30-Apr-2026 | 26-Jun-2026 | Final | ₹4.00 |
| 05-Feb-2026 | 30-Jan-2026 | 05-Feb-2026 | Interim 3 | ₹3.50 |
| 07-Nov-2025 | 31-Oct-2025 | 07-Nov-2025 | Interim 2 | ₹7.00 |
| 06-Aug-2025 | 31-Jul-2025 | 06-Aug-2025 | Interim | ₹6.00 |
LALPATHLAB Key Leadership Details
Last Updated: Mar 2026
| Name | Position |
|---|---|
| Arvind Lal | Chairman & Managing Director |
| Vandana Lal | WTD & Executive Directorector |
| Arun Duggal | Non Executive Independent Director |
Dr Lal Pathlabs Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Apollo Hospitals Enterprise LtdAPOLLOHOSP | ₹8,912.00-0.36% | ₹1,10,231.07 | 59.08 | 20.48% |
| Max Healthcare Institute LtdMAXHEALTH | ₹1,066.60+1.65% | ₹1,02,534.79 | 72.27 | 13.42% |
| Fortis Healthcare LtdFORTIS | ₹893.50+0.85% | ₹68,746.49 | 70.10 | 10.53% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Dr Lal Pathlabs Ltd today is ₹1,916.30 on NSE and ₹1,916.30 on BSE.
- The 52-week high of Dr Lal Pathlabs Ltd is ₹2,035.00, while the 52-week low is ₹1,272.00.
- The current market capitalisation of Dr Lal Pathlabs Ltd is approximately ₹32,165 crore.
- The P/E (Price-to-Earnings) ratio of Dr Lal Pathlabs Ltd is 42.71. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Dr Lal Pathlabs Ltd is 9.54. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Dr Lal Pathlabs Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for LALPATHLAB on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Dr Lal Pathlabs Ltd has delivered a return of approximately 60.41%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Dr Lal Pathlabs Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 53.19% promoters, -1.44% FIIs, 21.59% DIIs, and 6.25% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
